Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Neovascular glaucoma: from ischemic pathophysiology to drainage tubes and modern pharmacotherapy.

Created on 12 Nov 2026

Authors

João Victor Borges Gomes, Ivan Maynart Tavares

Published in

Arquivos brasileiros de oftalmologia. Volume 89. Issue 6. Pages e20260029. Epub Nov 09, 2026.

Abstract

This narrative review summarizes the pathophysiology, diagnosis, and management of neovascular glaucoma and provides a comprehensive guide for clinical ophthalmologists. An iterative snowballing approach, together with targeted searches of PubMed/MEDLINE, Embase, and the Cochrane Library, identified 81 studies addressing key aspects of neovascular glaucoma, including molecular mechanisms, advanced diagnostic modalities, and surgical strategies. Neovascular glaucoma is an aggressive form of secondary glaucoma driven by ischemia-induced upregulation of vascular endothelial growth factor and angiopoietin-2 through the hypoxia-inducible factor-1α pathway. Diagnosis is primarily based on clinical findings and is increasingly supported by advanced imaging techniques. Management requires a multimodal approach combining panretinal photocoagulation and anti-vascular endothelial growth factor therapy with intraocular pressure-lowering interventions, including glaucoma drainage devices, micropulse transscleral cyclophotocoagulation, and slow-coagulation transscleral cyclophotocoagulation. Glaucoma drainage devices achieve the greatest intraocular pressure reduction, whereas micropulse transscleral cyclophotocoagulation offers the most favorable safety profile. Slow-coagulation transscleral cyclophotocoagulation represents an intermediate option, with a reported success rate of 71.7% and favorable safety outcomes. Emerging therapies aim to provide sustained angiogenic control while targeting fibrosis and neuroprotection.

PMID:
43018022
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement